Quipt Home Medical Corp. (NASDAQ:QIPT – Get Rating) – Equities researchers at Raymond James dropped their Q4 2023 earnings estimates for Quipt Home Medical in a research report issued to clients and investors on Thursday, January 5th. Raymond James analyst R. Sarugaser now forecasts that the company will post earnings of $0.09 per share for the quarter, down from their previous estimate of $0.10. Raymond James has a "Outperform" rating and a $14.00 price objective on the stock. The consensus estimate for Quipt Home Medical's current full-year earnings is $0.29 per share. Raymond James also issued estimates for Quipt Home Medical's Q1 2024 earnings at $0.11 EPS, Q2 2024 earnings at $0.12 EPS, Q3 2024 earnings at $0.13 EPS, Q4 2024 earnings at $0.14 EPS, FY2025 earnings at $0.67 EPS and FY2026 earnings at $1.11 EPS.
Get
Quipt Home Medical alerts:
Separately, Canaccord Genuity Group lifted their target price on Quipt Home Medical from C$11.00 to C$11.25 in a research note on Monday, October 24th.
Quipt Home Medical Trading Up 0.7 %
Shares of QIPT opened at $5.58 on Friday. The business's 50-day moving average price is $4.54 and its 200 day moving average price is $4.69. The stock has a market capitalization of $198.68 million, a P/E ratio of 43.31 and a beta of 0.43. Quipt Home Medical has a 1-year low of $3.89 and a 1-year high of $6.00. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 0.14.
Quipt Home Medical (NASDAQ:QIPT – Get Rating) last issued its quarterly earnings results on Wednesday, December 21st. The company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.01. The firm had revenue of $40.09 million for the quarter, compared to analysts' expectations of $40.50 million. Quipt Home Medical had a return on equity of 7.13% and a net margin of 3.46%.
Hedge Funds Weigh In On Quipt Home Medical
Several institutional investors and hedge funds have recently bought and sold shares of QIPT. Raymond James Financial Services Advisors Inc. grew its stake in Quipt Home Medical by 13.9% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 33,100 shares of the company's stock valued at $145,000 after acquiring an additional 4,050 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of Quipt Home Medical by 1,709,900.0% in the 1st quarter. Acadian Asset Management LLC now owns 17,100 shares of the company's stock valued at $75,000 after buying an additional 17,099 shares in the last quarter. First Manhattan Co. grew its stake in shares of Quipt Home Medical by 56.9% in the 1st quarter. First Manhattan Co. now owns 951,250 shares of the company's stock valued at $4,175,000 after buying an additional 345,000 shares in the last quarter. Royal Bank of Canada grew its stake in shares of Quipt Home Medical by 24.6% in the 1st quarter. Royal Bank of Canada now owns 12,327 shares of the company's stock valued at $54,000 after buying an additional 2,437 shares in the last quarter. Finally, Bank of America Corp DE grew its stake in shares of Quipt Home Medical by 59.8% in the 1st quarter. Bank of America Corp DE now owns 29,641 shares of the company's stock valued at $130,000 after buying an additional 11,096 shares in the last quarter. Hedge funds and other institutional investors own 26.14% of the company's stock.
Quipt Home Medical Company Profile
(Get Rating)
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions.
Featured Articles
- Get a free copy of the StockNews.com research report on Quipt Home Medical (QIPT)
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don't Buy It Just Yet
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.
